Skip to content

Radifocus Glidewire Advantage Track

by Ashitaka Factory of Terumo Coporation

510(k) K163004

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK163004 Date30 Jan 2017ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DQX
Device Class
Class II
Regulation
21 CFR Part 870.1330
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Radifocus Glidewire Advantage Track is a peripheral guidewire designed to direct a catheter to the desired anatomical location, including use as a lower limb guide wire during diagnostic or interventional procedures. It features a hybrid wire design for enhanced torque control and support, aiding navigation of complex peripheral vascular challenges.

This device is supplied by the manufacturer Ashitaka Factory of Terumo Corporation and has received FDA 510(k) clearance under K163004 with product code DQX. It is intended for use in peripheral vascular interventions, including ilio-femoro-popliteal and below-the-knee treatments, and supports catheter placement from sheath insertion to target lesion crossing.

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Radifocus Glidewire Advantage Track used for?

    It is designed to direct a catheter to the desired anatomical location, including use as a lower limb guide wire during diagnostic or interventional peripheral vascular procedures, supporting navigation from sheath insertion to target lesion crossing in ilio-femoro-popliteal and below-the-knee treatments.

  • How is the Radifocus Glidewire Advantage Track supplied and is it sterile?

    The device is supplied by the manufacturer Ashitaka Factory of Terumo Corporation; however, the provided data does not specify sterility or single-use/reuse status, so no conclusion can be drawn about its supply format or sterility from the given information.

  • What regulatory clearance does the Radifocus Glidewire Advantage Track have?

    It has received FDA 510(k) clearance under K163004 with product code DQX, as stated in the device data, indicating it was found substantially equivalent to a legally marketed predicate device.